Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 7,741 | 8,405 | 8,029 | 7,656 | 6,315 |
| Operating Income | -7,741 | -8,405 | -8,029 | -7,656 | -6,315 |
| Other Income | 1,150 | -774 | 392 | 1,726 | -1,157 |
| Pre-tax Income | -6,591 | -9,180 | -7,637 | -5,930 | -7,472 |
| Net Income Continuous | -6,591 | -9,180 | -7,637 | -5,930 | -7,472 |
| Net Income | $-6,591 | $-9,180 | $-7,637 | $-5,930 | $-7,472 |
| EPS Basic Total Ops | -0.10 | -0.14 | -0.12 | -0.09 | -0.12 |
| EPS Basic Continuous Ops | -0.10 | -0.14 | -0.12 | -0.09 | -0.12 |
| EPS Diluted Total Ops | -0.10 | -0.14 | -0.12 | -0.09 | -0.12 |
| EPS Diluted Continuous Ops | -0.10 | -0.14 | -0.12 | -0.09 | -0.12 |
| EBITDA(a) | $-7,679 | $-8,344 | $-7,962 | $-7,591 | $-6,256 |